Compare MYFW & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MYFW | XBIT |
|---|---|---|
| Founded | 2002 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 255.0M | 73.2M |
| IPO Year | 2018 | 2015 |
| Metric | MYFW | XBIT |
|---|---|---|
| Price | $25.84 | $2.54 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $24.25 | N/A |
| AVG Volume (30 Days) | 32.3K | ★ 48.6K |
| Earning Date | 01-22-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 391.62 | N/A |
| EPS | ★ 1.28 | N/A |
| Revenue | ★ $95,514,000.00 | N/A |
| Revenue This Year | $15.96 | N/A |
| Revenue Next Year | $13.77 | N/A |
| P/E Ratio | $20.46 | ★ N/A |
| Revenue Growth | ★ 19.92 | N/A |
| 52 Week Low | $17.10 | $2.09 |
| 52 Week High | $28.00 | $4.67 |
| Indicator | MYFW | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 57.27 | 54.73 |
| Support Level | $25.49 | $2.40 |
| Resistance Level | $27.15 | $2.55 |
| Average True Range (ATR) | 0.68 | 0.09 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 24.53 | 84.62 |
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.